Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $1,700.0K | $79.3M | $130.5M | $113.0M | $128.9M | $229.1M | $218.0M | $236.7M | $293.2M | $391.7M | $811.1M | $494.9M | $569.5M | $622.1M | $722.2M | $1,046.9M | $823.4M | $1,503.1M | $1,521.9M | $1,402.4M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Edwards Lifesciences Corporation's last 12-month Net Income is $4,158.9M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Edwards Lifesciences Corporation's Net Income growth was 190.6%. The average annual Net Income growth rates for Edwards Lifesciences Corporation have been 69.7% over the past three years, 40.0% over the past five years.
Over the last year, Edwards Lifesciences Corporation's Net Income growth was 190.6%, which is higher than industry growth of (0.2%). It indicates that Edwards Lifesciences Corporation's Net Income growth is Good.